FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Pieter Limburg

Research Profile

Chemicals & Drugs

Disorders

Procedures

Enzyme-Linked Immunosorbent Assay

Concepts & Ideas

Anatomy

Neutrophils

Co-author Network

Publications

TOP 3
A W S de Souza; Pieter C Limburg; Jantine L Westra; Marc Bijl; C G M Kallenberg
HMGB1 in vascular diseases: Its role in vascular inflammation and atherosclerosis.
Sebastian Dolff; Minke G Huitema; Cees G M Kallenberg; Pieter C Limburg; Marc Bijl; Wayel Habib Abdulahad
Disturbed Th1, Th2, Th17 and T(reg) balance in patients with systemic lupus erythematosus.
Jose Stam; Margriet van Stuijvenberg; Wayel Habib Abdulahad; Minke G Huitema; Pieter C Limburg; Caroline Roozendaal; Elisabeth H Schölvinck
Fluorescent cell barcoding as a tool to assess the age-related development of intracellular cytokine production in small amounts of blood from infants.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Pieter Limburg (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: A W S de Souza; Pieter C Limburg; Jantine L Westra; Marc Bijl; C G M Kallenberg
HMGB1 in vascular diseases: Its role in vascular inflammation and atherosclerosis.
Autoimmunity reviews 2012;11(12):909-17.
2011: Sebastian Dolff; Minke G Huitema; Cees G M Kallenberg; Pieter C Limburg; Marc Bijl; Wayel Habib Abdulahad
Disturbed Th1, Th2, Th17 and T(reg) balance in patients with systemic lupus erythematosus.
Clinical immunology (Orlando, Fla.) 2011;141(2):197-204.
2011: Jose Stam; Margriet van Stuijvenberg; Wayel Habib Abdulahad; Minke G Huitema; Pieter C Limburg; Caroline Roozendaal; Elisabeth H Schölvinck
Fluorescent cell barcoding as a tool to assess the age-related development of intracellular cytokine production in small amounts of blood from infants.
PloS one 2011;6(10):e25690.
2011: Sebastian Dolff; Berber Doornbos-Van der Meer; Cees G M Kallenberg; Pieter C Limburg; Jantine L Westra; Wayel Habib Abdulahad; Marc Bijl
Increase in IL-21 producing T-cells in patients with systemic lupus erythematosus.
Arthritis research & therapy 2011;13(5):R157.
2011: Deena A Abdulahad; Johan Bijzet; Cees G M Kallenberg; Pieter C Limburg; Jantine L Westra; Marc Bijl
High mobility group box 1 (HMGB1) and anti-HMGB1 antibodies and their relation to disease characteristics in systemic lupus erythematosus.
Arthritis research & therapy 2011;13(3):R71.
2010: Netty G P Bos-Veneman; Johan Bijzet; Pieter C Limburg; Ruud B Minderaa; Cees G Kallenberg; Pieter J Hoekstra
Cytokines and soluble adhesion molecules in children and adolescents with a tic disorder.
Progress in neuro-psychopharmacology & biological psychiatry 2010;34(8):1390-5.
2010: Sebastian Dolff; Wayel Habib Abdulahad; Marcory C R F van Dijk; Pieter C Limburg; Cees G M Kallenberg; Marc Bijl
Urinary T cells in active lupus nephritis show an effector memory phenotype.
Annals of the rheumatic diseases 2010;69(11):2034-41.
2010: Suzanne Arends; H R Lebbink; Anneke Spoorenberg; L B Bungener; Caroline Roozendaal; Eveline van der Veer; Pieternella Houtman; E N Griep; Pieter C Limburg; Cees G M Kallenberg; G J Wolbink; Elisabeth Brouwer
The formation of autoantibodies and antibodies to TNF-α blocking agents in relation to clinical response in patients with ankylosing spondylitis.
Clinical and experimental rheumatology 2010;28(5):661-8.
2010: D A Abdulahad; Jantine L Westra; Pieter C Limburg; C G M Kallenberg; Marc Bijl
HMGB1 in systemic lupus Erythematosus: Its role in cutaneous lesions development.
Autoimmunity reviews 2010;9(10):661-5.
2009: Elisabeth Brouwer; A S H Gouw; Marcel D Posthumus; Miek A van Leeuwen; A L Boerboom; Johan Bijzet; R Bos; Pieter C Limburg; C G M Kallenberg; Jantine L Westra
Hypoxia inducible factor-1-alpha (HIF-1alpha) is related to both angiogenesis and inflammation in rheumatoid arthritis.
Clinical and experimental rheumatology 2009;27(6):945-51.
2009: Jantine L Westra; Elisabeth Brouwer; Erwin Bouwman; Berber Doornbos-Van der Meer; Marcel D Posthumus; Miek A van Leeuwen; Pieter C Limburg; Yutaka Ueda; Cees G M Kallenberg
Role for CaMKII inhibition in rheumatoid arthritis: effects on HIF-1-induced VEGF production by rheumatoid synovial fibroblasts.
Annals of the New York Academy of Sciences 2009;1173():706-11.
2009: Wayel Habib Abdulahad; Cees G M Kallenberg; Pieter C Limburg; Coen A Stegeman
Urinary CD4+ effector memory T cells reflect renal disease activity in antineutrophil cytoplasmic antibody-associated vasculitis.
Arthritis and rheumatism 2009;60(9):2830-8.
2009: Hans L A Nienhuis; Johanna Westra; Andries J Smit; Pieter C Limburg; Cees G M Kallenberg; Marc Bijl
AGE and their receptor RAGE in systemic autoimmune diseases: an inflammation propagating factor contributing to accelerated atherosclerosis.
Autoimmunity 2009;42(4):302-4.
2009: N Hu; J Westra; Minke G Huitema; Marc Bijl; Elisabeth Brouwer; Coen A Stegeman; Peter Heeringa; Pieter C Limburg; C G M Kallenberg
Coexpression of CD177 and membrane proteinase 3 on neutrophils in antineutrophil cytoplasmic autoantibody-associated systemic vasculitis: anti-proteinase 3-mediated neutrophil activation is independent of the role of CD177-expressing neutrophils.
Arthritis and rheumatism 2009;60(5):1548-57.
2008: Wayel Habib Abdulahad; Coen A Stegeman; Pieter C Limburg; Cees G M Kallenberg
Skewed distribution of Th17 lymphocytes in patients with Wegener's granulomatosis in remission.
Arthritis and rheumatism 2008;58(7):2196-205.
2008: Esther Reefman; H Kuiper; Pieter C Limburg; C G M Kallenberg; Marc Bijl
Type I interferons are involved in the development of ultraviolet B-induced inflammatory skin lesions in systemic lupus erythaematosus patients.
Annals of the rheumatic diseases 2008;67(1):11-18.
2007: H S Schipper; Bea Rutgers; Minke G Huitema; Samuel Etuaful; B Daan Westenbrink; Pieter C Limburg; Wim Timens; Tjip S van der Werf
Systemic and local interferon-gamma production following Mycobacterium ulcerans infection.
Clinical and experimental immunology 2007;150(3):451-9.
2007: Ymke M van der Geld; Thomas Hellmark; Daina Selga; Peter Heeringa; Minke G Huitema; Pieter C Limburg; Cees G M Kallenberg
Rats and mice immunised with chimeric human/mouse proteinase 3 produce autoantibodies to mouse Pr3 and rat granulocytes.
Annals of the rheumatic diseases 2007;66(12):1679-82.
2007: Esther Reefman; Gerda Horst; Marije T Nijk; Pieter C Limburg; Cees G M Kallenberg; Marc Bijl
Opsonization of late apoptotic cells by systemic lupus erythematosus autoantibodies inhibits their uptake via an Fcgamma receptor-dependent mechanism.
Arthritis and rheumatism 2007;56(10):3399-411.
2007: André P van Rossum; Minke G Huitema; Coen A Stegeman; Marc Bijl; Karina de Leeuw; Miek A van Leeuwen; Pieter C Limburg; Cees G M Kallenberg
Standardised assessment of membrane proteinase 3 expression. Analysis in ANCA-associated vasculitis and controls.
Annals of the rheumatic diseases 2007;66(10):1350-5.
2007: Jantine L Westra; Elisabeth Brouwer; Reinhard Bos; Marcel D Posthumus; Berber Doornbos-Van der Meer; Cees G M Kallenberg; Pieter C Limburg
Regulation of cytokine-induced HIF-1alpha expression in rheumatoid synovial fibroblasts.
Annals of the New York Academy of Sciences 2007;1108():340-8.
2007: Wayel Habib Abdulahad; Coen A Stegeman; Pieter C Limburg; Cees G M Kallenberg
CD4-positive effector memory T cells participate in disease expression in ANCA-associated vasculitis.
Annals of the New York Academy of Sciences 2007;1107():22-31.
2007: Bouke P C Hazenberg; Johan Bijzet; Pieter C Limburg; Martha Skinner; Philip N Hawkins; Irena Butrimiene; Avi Livneh; Olga Lesnyak; Evgeney L Nasonov; Anna Filipowicz-Sosnowska; Ahmet Gül; Giampaolo Merlini; Piotr Wiland; Huri Ozdogan; Peter D Gorevic; Hédi Ben Maïz; Merrill D Benson; Haner Direskeneli; Kalevi Kaarela; Denis Garceau; Wendy Hauck; Martin H van Rijswijk
Diagnostic performance of amyloid A protein quantification in fat tissue of patients with clinical AA amyloidosis.
Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis 2007;14(2):133-40.
2007: Wayel Habib Abdulahad; Coen A Stegeman; Ymke M van der Geld; Berber Doornbos-Van der Meer; Pieter C Limburg; Cees G M Kallenberg
Functional defect of circulating regulatory CD4+ T cells in patients with Wegener's granulomatosis in remission.
Arthritis and rheumatism 2007;56(6):2080-91.
2007: Marc Bijl; Esther Reefman; Pieter C Limburg; Cees G M Kallenberg
Inflammatory clearance of apoptotic cells after UVB challenge.
Autoimmunity 2007;40(4):244-8.
2006: Esther Reefman; Pieter C Limburg; Cees G M Kallenberg; Marc Bijl
Do apoptotic cells accumulate in the epidermis of patients with cutaneous lupus erythematosus after ultraviolet irradiation? Comment on the article by Kuhn et al.
Arthritis and rheumatism 2006;54(10):3373-4.
2006: Jantine L Westra; Pieter C Limburg
p38 mitogen-activated protein kinase (MAPK) in rheumatoid arthritis.
Mini reviews in medicinal chemistry 2006;6(8):867-74.
2006: Jantine L Westra; Johan Bijzet; Berber Doornbos-Van der Meer; Martin H van Rijswijk; Pieter C Limburg
Differential influence of p38 mitogen activated protein kinase (MAPK) inhibition on acute phase protein synthesis in human hepatoma cell lines.
Annals of the rheumatic diseases 2006;65(7):929-35.
2006: Esther Reefman; Hilde Kuiper; Marcel F Jonkman; Pieter C Limburg; Cees G M Kallenberg; Marc Bijl
Skin sensitivity to UVB irradiation in systemic lupus erythematosus is not related to the level of apoptosis induction in keratinocytes.
Rheumatology (Oxford, England) 2006;45(5):538-44.
2006: André P van Rossum; Hendri H Pas; Fausto Fazzini; Minke G Huitema; Pieter C Limburg; Marcel F Jonkman; Cees G M Kallenberg
Abundance of the long pentraxin PTX3 at sites of leukocytoclastic lesions in patients with small-vessel vasculitis.
Arthritis and rheumatism 2006;54(3):986-91.
2006: Esther Reefman; Marcelus C J M de Jong; Hilde Kuiper; Marcel F Jonkman; Pieter C Limburg; Cees G M Kallenberg; Marc Bijl
Is disturbed clearance of apoptotic keratinocytes responsible for UVB-induced inflammatory skin lesions in systemic lupus erythematosus?
Arthritis research & therapy 2006;8(6):R156.
2006: Cees G M Kallenberg; Coen A Stegeman; Hendrika Bootsma; Marc Bijl; Pieter C Limburg
Quantitation of autoantibodies in systemic autoimmune diseases: clinically useful?
Lupus 2006;15(7):397-402.
2006: Marc Bijl; Esther Reefman; Gerda Horst; Pieter C Limburg; Cees G M Kallenberg
Reduced uptake of apoptotic cells by macrophages in systemic lupus erythematosus: correlates with decreased serum levels of complement.
Annals of the rheumatic diseases 2006;65(1):57-63.
2005: Joanna M Kuldo; Jantine L Westra; Sigridur A Asgeirsdóttir; Robbert J Kok; Koen Oosterhuis; Marianne G Rots; Jan Schouten; Pieter C Limburg; Grietje Molema
Differential effects of NF-{kappa}B and p38 MAPK inhibitors and combinations thereof on TNF-{alpha}- and IL-1{beta}-induced proinflammatory status of endothelial cells in vitro.
American journal of physiology. Cell physiology 2005;289(5):C1229-39.
2005: André P van Rossum; Ymke M van der Geld; Pieter C Limburg; Cees G M Kallenberg
Human anti-neutrophil cytoplasm autoantibodies to proteinase 3 (PR3-ANCA) bind to neutrophils.
Kidney international 2005;68(2):537-41.
2005: Jantine L Westra; Joanna M Kułdo; Martin H van Rijswijk; Grietje Molema; Pieter C Limburg
Chemokine production and E-selectin expression in activated endothelial cells are inhibited by p38 MAPK (mitogen activated protein kinase) inhibitor RWJ 67657.
International immunopharmacology 2005;5(7-8):1259-69.
2005: Esther Reefman; Pieter C Limburg; Cees G M Kallenberg; Marc Bijl
Apoptosis in human skin: role in pathogenesis of various diseases and relevance for therapy.
Annals of the New York Academy of Sciences 2005;1051():52-63.
2005: André P van Rossum; Pieter C Limburg; Cees G M Kallenberg
Activation, apoptosis, and clearance of neutrophils in Wegener's granulomatosis.
Annals of the New York Academy of Sciences 2005;1051():1-11.
2005: M E Grevink; Gerda Horst; Pieter C Limburg; Cees G M Kallenberg; Marc Bijl
Levels of complement in sera from inactive SLE patients, although decreased, do not influence in vitro uptake of apoptotic cells.
Journal of autoimmunity 2005;24(4):329-36.
2005: B Daan Westenbrink; Ymkje Stienstra; Minke G Huitema; William A Thompson; Erasmus O Klutse; Edwin O Ampadu; H Marike Boezen; Pieter C Limburg; Tjip S van der Werf
Cytokine responses to stimulation of whole blood from patients with Buruli ulcer disease in Ghana.
Clinical and diagnostic laboratory immunology 2005;12(1):125-9.
2004: André P van Rossum; Agnieszka Rarok; Minke G Huitema; Giorgio Fassina; Pieter C Limburg; Cees G M Kallenberg
Constitutive membrane expression of proteinase 3 (PR3) and neutrophil activation by anti-PR3 antibodies.
Journal of leukocyte biology 2004;76(6):1162-70.
2004: Koert P de Jong; R M J Hoedemakers; Vaclav Fidler; Johan Bijzet; Pieter C Limburg; Paul M J G Peeters; E G E de Vries; Maarten J H Slooff
Portal and systemic serum growth factor and acute-phase response after laparotomy or partial hepatectomy in patients with colorectal liver metastases: a prognostic role for C-reactive protein and hepatocyte growth factor.
Scandinavian journal of gastroenterology 2004;39(11):1141-8.
2004: Jantine L Westra; Pieter C Limburg; Peter de Boer; Martin H van Rijswijk
Effects of RWJ 67657, a p38 mitogen activated protein kinase (MAPK) inhibitor, on the production of inflammatory mediators by rheumatoid synovial fibroblasts.
Annals of the rheumatic diseases 2004;63(11):1453-9.
2004: André P van Rossum; Fausto Fazzini; Pieter C Limburg; angelo manfredi; Patrizia Rovere-Querini; Alberto Mantovani; Cees G M Kallenberg
The prototypic tissue pentraxin PTX3, in contrast to the short pentraxin serum amyloid P, inhibits phagocytosis of late apoptotic neutrophils by macrophages.
Arthritis and rheumatism 2004;50(8):2667-74.
2004: Pieter J Hoekstra; Johan Bijzet; Pieter C Limburg; Cees G M Kallenberg; Ruud B Minderaa
Elevated binding of D8/17-specific monoclonal antibody to B lymphocytes in Tic disorder patients.
The American journal of psychiatry 2004;161(8):1501-2.
2004: Marc Bijl; Hendrika Bootsma; Ymke M van der Geld; Pieter C Limburg; Cees G M Kallenberg; Martin H van Rijswijk
Serum amyloid P component levels are not decreased in patients with systemic lupus erythematosus and do not rise during an acute phase reaction.
Annals of the rheumatic diseases 2004;63(7):831-5.
2004: Abraham Rutgers; J G M C Damoiseaux; Caroline Roozendaal; Pieter C Limburg; Coen A Stegeman; J W Cohen Tervaert
ANCA-GBM dot-blot: evaluation of an assay in the differential diagnosis of patients presenting with rapidly progressive glomerulonephritis.
Journal of clinical immunology 2004;24(4):435-40.
2004: Pieter J Hoekstra; george anderson; Pieter C Limburg; Jakob Korf; Cees G M Kallenberg; Ruud B Minderaa
Neurobiology and neuroimmunology of Tourette's syndrome: an update.
Cellular and molecular life sciences : CMLS 2004;61(7-8):886-98.
2004: Jantine L Westra; Berber Doornbos-Van der Meer; Peter de Boer; Miek A van Leeuwen; Martin H van Rijswijk; Pieter C Limburg
Strong inhibition of TNF-alpha production and inhibition of IL-8 and COX-2 mRNA expression in monocyte-derived macrophages by RWJ 67657, a p38 mitogen-activated protein kinase (MAPK) inhibitor.
Arthritis research & therapy 2004;6(4):R384-92.
2003: Agnieszka Rarok; Ymke M van der Geld; Coen A Stegeman; Pieter C Limburg; Cees G M Kallenberg
Diversity of PR3-ANCA epitope specificity in Wegener's granulomatosis. Analysis using the biosensor technology.
Journal of clinical immunology 2003;23(6):460-8.
2003: André P van Rossum; Pieter C Limburg; Cees G M Kallenberg
Membrane proteinase 3 expression on resting neutrophils as a pathogenic factor in PR3-ANCA-associated vasculitis.
Clinical and experimental rheumatology 2003;21(6 Suppl 32):S64-8.
2003: Agnieszka Rarok; Minke G Huitema; Marcel J van der Leij; Ymke M van der Geld; Heike Berthold; Jacky Schmitt; Coen A Stegeman; Pieter C Limburg; Cees G M Kallenberg
Recombinant protein to analyze autoantibodies to proteinase 3 in systemic vasculitis.
American journal of clinical pathology 2003;120(4):586-95.
2003: Esther Reefman; Hilde M Dijstelbloem; Pieter C Limburg; Cees G M Kallenberg; Marc Bijl
Fcgamma receptors in the initiation and progression of systemic lupus erythematosus.
Immunology and cell biology 2003;81(5):382-9.
2003: Pieter J Hoekstra; Gerda Horst; Pieter C Limburg; Pieter W Troost; Natasja D J van Lang; Annelies de Bildt; Jakob Korf; Cees G M Kallenberg; Ruud B Minderaa
Increased seroreactivity in tic disorder patients to a 60 kDa protein band from a neuronal cell line.
Journal of neuroimmunology 2003;141(1-2):118-24.
2003: Marcel D Posthumus; Pieter C Limburg; Jantine L Westra; Miek A van Leeuwen; Martin H van Rijswijk
Serum matrix metalloproteinase 3 levels in comparison to C-reactive protein in periods with and without progression of radiological damage in patients with early rheumatoid arthritis.
Clinical and experimental rheumatology 2003;21(4):465-72.
2003: Agnieszka Rarok; Pieter C Limburg; Cees G M Kallenberg
Neutrophil-activating potential of antineutrophil cytoplasm autoantibodies.
Journal of leukocyte biology 2003;74(1):3-15.
2003: Marc Bijl; Gerda Horst; Hendrika Bootsma; Pieter C Limburg; Cees G M Kallenberg
Mycophenolate mofetil prevents a clinical relapse in patients with systemic lupus erythematosus at risk.
Annals of the rheumatic diseases 2003;62(6):534-9.
2003: Marc Bijl; Gerda Horst; Johan Bijzet; Hendrika Bootsma; Pieter C Limburg; Cees G M Kallenberg
Serum amyloid P component binds to late apoptotic cells and mediates their uptake by monocyte-derived macrophages.
Arthritis and rheumatism 2003;48(1):248-54.
2002: Tim Jansen; Pieter J Hoekstra; Johan Bijzet; Pieter C Limburg; Ed N Griep
Elevation of D8/17-positive B lymphocytes in only a minority of Dutch patients with post-streptococcal reactive arthritis (PSRA): a pilot study.
Rheumatology (Oxford, England) 2002;41(10):1202-3.
2002: Ymke M van der Geld; Anton T J Tool; J Videler; Masja de Haas; J W Cohen Tervaert; Coen A Stegeman; Pieter C Limburg; Cees G M Kallenberg; Dirk Roos
Interference of PR3-ANCA with the enzymatic activity of PR3: differences in patients during active disease or remission of Wegener's granulomatosis.
Clinical and experimental immunology 2002;129(3):562-70.
2002: Agnieszka Rarok; Coen A Stegeman; Pieter C Limburg; Cees G M Kallenberg
Neutrophil membrane expression of proteinase 3 (PR3) is related to relapse in PR3-ANCA-associated vasculitis.
Journal of the American Society of Nephrology : JASN 2002;13(9):2232-8.
2002: Eliane R Popa; Casper F M Franssen; Pieter C Limburg; Minke G Huitema; Cees G M Kallenberg; J W Cohen Tervaert
In vitro cytokine production and proliferation of T cells from patients with anti-proteinase 3- and antimyeloperoxidase-associated vasculitis, in response to proteinase 3 and myeloperoxidase.
Arthritis and rheumatism 2002;46(7):1894-904.
2002: Ymke M van der Geld; Marjan Smook; Minke G Huitema; Martin C Harmsen; Pieter C Limburg; Cees G M Kallenberg
Expression of recombinant proteinase 3, the autoantigen in Wegener's granulomatosis, in insect cells.
Journal of immunological methods 2002;264(1-2):195-205.
2002: Marcel D Posthumus; Pieter C Limburg; Jantine L Westra; Miek A van Leeuwen; Martin H van Rijswijk
Serum matrix metalloproteinase 3 levels during treatment with sulfasalazine or combination of methotrexate and sulfasalazine in patients with early rheumatoid arthritis.
The Journal of rheumatology 2002;29(5):883-9.
2002: Robert J van Ginkel; Pieter C Limburg; D Albertus Piers; Heimen Schraffordt Koops; Harald J Hoekstra
Value of continuous leakage monitoring with radioactive iodine-131-labeled human serum albumin during hyperthermic isolated limb perfusion with tumor necrosis factor-alpha and melphalan.
Annals of surgical oncology 2002;9(4):355-63.
2002: Cees G M Kallenberg; Agnieszka Rarok; Coen A Stegeman; Pieter C Limburg
New insights into the pathogenesis of antineutrophil cytoplasmic autoantibody-associated vasculitis.
Autoimmunity reviews 2002;1(1-2):61-6.
2002: Marc Bijl; Hilde M Dijstelbloem; WW Oost; Hendrika Bootsma; R H W M Derksen; J Aten; Pieter C Limburg; Cees G M Kallenberg
IgG subclass distribution of autoantibodies differs between renal and extra-renal relapses in patients with systemic lupus erythematosus.
Rheumatology (Oxford, England) 2002;41(1):62-7.
2002: T M El Mansoury; Bouke P C Hazenberg; S A El Badawy; A H Ahmed; Johan Bijzet; Pieter C Limburg; Martin H van Rijswijk
Screening for amyloid in subcutaneous fat tissue of Egyptian patients with rheumatoid arthritis: clinical and laboratory characteristics.
Annals of the rheumatic diseases 2002;61(1):42-7.
2001: Maarten M Boomsma; Coen A Stegeman; WW Oost-Kort; Cees G M Kallenberg; Nicole Moguilevsky; Pieter C Limburg; J W Cohen Tervaert
Native and recombinant proteins to analyze auto-antibodies to myeloperoxidase in pauci-immune crescentic glomerulonephritis.
Journal of immunological methods 2001;254(1-2):47-58.
2001: Koert P de Jong; M M van Gameren; Johan Bijzet; Pieter C Limburg; W J Sluiter; Maarten J H Slooff; E G de Vries
Recombinant human interleukin-6 induces hepatocyte growth factor production in cancer patients.
Scandinavian journal of gastroenterology 2001;36(6):636-40.
2001: Marc Bijl; Gerda Horst; Pieter C Limburg; Cees G M Kallenberg
Effects of smoking on activation markers, Fas expression and apoptosis of peripheral blood lymphocytes.
European journal of clinical investigation 2001;31(6):550-3.
2001: Marc Bijl; Gerda Horst; Pieter C Limburg; Cees G M Kallenberg
Expression of costimulatory molecules on peripheral blood lymphocytes of patients with systemic lupus erythematosus.
Annals of the rheumatic diseases 2001;60(5):523-6.
2001: Pieter J Hoekstra; Johan Bijzet; Pieter C Limburg; Mark-Peter Steenhuis; Pieter W Troost; M D Oosterhoff; Jakob Korf; Cees G M Kallenberg; Ruud B Minderaa
Elevated D8/17 expression on B lymphocytes, a marker of rheumatic fever, measured with flow cytometry in tic disorder patients.
The American journal of psychiatry 2001;158(4):605-10.
2001: Koert P de Jong; B A von Geusau; C A Rottier; Johan Bijzet; Pieter C Limburg; E G E de Vries; Vaclav Fidler; Maarten J H Slooff
Serum response of hepatocyte growth factor, insulin-like growth factor-I, interleukin-6, and acute phase proteins in patients with colorectal liver metastases treated with partial hepatectomy or cryosurgery.
Journal of hepatology 2001;34(3):422-7.
2001: Ymke M van der Geld; Pieter C Limburg; Cees G M Kallenberg
Proteinase 3, Wegener's autoantigen: from gene to antigen.
Journal of leukocyte biology 2001;69(2):177-90.
2001: Marc Bijl; Gerda Horst; Pieter C Limburg; Cees G M Kallenberg
Fas expression on peripheral blood lymphocytes in systemic lupus erythematosus (SLE): relation to lymphocyte activation and disease activity.
Lupus 2001;10(12):866-72.
2001: Marc Bijl; Gerda Horst; Pieter C Limburg; Cees G M Kallenberg
Anti-CD3-induced and anti-Fas-induced apoptosis in systemic lupus erythematosus (SLE).
Clinical and experimental immunology 2001;123(1):127-32.
2001: Ymke M van der Geld; A Simpelaar; Ruurd van der Zee; J W Cohen Tervaert; Coen A Stegeman; Pieter C Limburg; Cees G M Kallenberg
Antineutrophil cytoplasmic antibodies to proteinase 3 in Wegener's granulomatosis: epitope analysis using synthetic peptides.
Kidney international 2001;59(1):147-59.
2000: Hilde M Dijstelbloem; Marc Bijl; R Fijnheer; RH Scheepers; WW Oost; Marc D Jansen; Wim J Sluiter; Pieter C Limburg; R H W M Derksen; Jan G J van de Winkel; Cees G M Kallenberg
Fcgamma receptor polymorphisms in systemic lupus erythematosus: association with disease and in vivo clearance of immune complexes.
Arthritis and rheumatism 2000;43(12):2793-800.
2000: Marcel D Posthumus; Pieter C Limburg; Jantine L Westra; Miek A van Leeuwen; Martin H van Rijswijk
Serum matrix metalloproteinase 3 in early rheumatoid arthritis is correlated with disease activity and radiological progression.
The Journal of rheumatology 2000;27(12):2761-8.
2000: Ymke M van der Geld; Minke G Huitema; Casper F M Franssen; Ruurd van der Zee; Pieter C Limburg; Cees G M Kallenberg
In vitro T lymphocyte responses to proteinase 3 (PR3) and linear peptides of PR3 in patients with Wegener's granulomatosis (WG).
Clinical and experimental immunology 2000;122(3):504-13.
2000: Ymke M van der Geld; WW Oost-Kort; Pieter C Limburg; U Specks; Cees G M Kallenberg
Recombinant proteinase 3 produced in different expression systems: recognition by anti-PR3 antibodies.
Journal of immunological methods 2000;244(1-2):117-31.
2000: Maarten M Boomsma; Coen A Stegeman; M J van der Leij; WW Oost; J Hermans; Cees G M Kallenberg; Pieter C Limburg; J W Cohen Tervaert
Prediction of relapses in Wegener's granulomatosis by measurement of antineutrophil cytoplasmic antibody levels: a prospective study.
Arthritis and rheumatism 2000;43(9):2025-33.
2000: John K Maring; Ids J Klompmaker; Jan H Zwaveling; Jan van der Meer; Pieter C Limburg; Maarten J H Slooff
Endotoxins and cytokines during liver transplantation: changes in plasma levels and effects on clinical outcome.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2000;6(4):480-8.
2000: Caroline Roozendaal; M A de Jong; Aad P van den Berg; RT van Wijk; Pieter C Limburg; Cees G M Kallenberg
Clinical significance of anti-neutrophil cytoplasmic antibodies (ANCA) in autoimmune liver diseases.
Journal of hepatology 2000;32(5):734-41.
2000: RH Brons; H I Bakker; RT van Wijk; N W Van Dijk; Anneke C Muller Kobold; Pieter C Limburg; Willem L Manson; Cees G M Kallenberg; J W Cohen Tervaert
Staphylococcal acid phosphatase binds to endothelial cells via charge interaction; a pathogenic role in Wegener's granulomatosis?
Clinical and experimental immunology 2000;119(3):566-73.
2000: Maarten W N Nijsten; Peter Olinga; T Hauw The; E G de Vries; Heimen Schraffordt Koops; Geny M M Groothuis; Pieter C Limburg; Henk Jan ten Duis; Han Moshage; H J Hoekstra; Johan Bijzet; Jan H Zwaveling
Procalcitonin behaves as a fast responding acute phase protein in vivo and in vitro.
Critical care medicine 2000;28(2):458-61.
1999: Ymke M van der Geld; Pieter C Limburg; Cees G M Kallenberg
Characterization of monoclonal antibodies to proteinase 3 (PR3) as candidate tools for epitope mapping of human anti-PR3 autoantibodies.
Clinical and experimental immunology 1999;118(3):487-96.
1999: Caroline Roozendaal; K Pogány; Gerda Horst; T G Jagt; Jan H Kleibeuker; GF Nelis; Pieter C Limburg; Cees G M Kallenberg
Does analysis of the antigenic specificities of anti-neutrophil cytoplasmic antibodies contribute to their clinical significance in the inflammatory bowel diseases?
Scandinavian journal of gastroenterology 1999;34(11):1123-31.
1999: Marcel D Posthumus; Pieter C Limburg; Jantine L Westra; H A Cats; R E Stewart; Miek A van Leeuwen; Martin H van Rijswijk
Serum levels of matrix metalloproteinase-3 in relation to the development of radiological damage in patients with early rheumatoid arthritis.
Rheumatology (Oxford, England) 1999;38(11):1081-7.
1999: Caroline Roozendaal; K Pogány; E J Hummel; Gerda Horst; G Dijkstra; GF Nelis; Pieter C Limburg; Jan H Kleibeuker; Cees G M Kallenberg
Titres of anti-neutrophil cytoplasmic antibodies in inflammatory bowel disease are not related to disease activity.
QJM : monthly journal of the Association of Physicians 1999;92(11):651-8.
1999: Casper F M Franssen; Minke G Huitema; Anneke C Muller Kobold; WW Oost-Kort; Pieter C Limburg; Anton T M G Tiebosch; Coen A Stegeman; Cees G M Kallenberg; J W Cohen Tervaert
In vitro neutrophil activation by antibodies to proteinase 3 and myeloperoxidase from patients with crescentic glomerulonephritis.
Journal of the American Society of Nephrology : JASN 1999;10(7):1506-15.
1999: Anneke C Muller Kobold; Ymke M van der Geld; Pieter C Limburg; J W Cohen Tervaert; Cees G M Kallenberg
Pathophysiology of ANCA-associated glomerulonephritis.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1999;14(6):1366-75.
1999: Bouke P C Hazenberg; Pieter C Limburg; Johan Bijzet; Martin H van Rijswijk
A quantitative method for detecting deposits of amyloid A protein in aspirated fat tissue of patients with arthritis.
Annals of the rheumatic diseases 1999;58(2):96-102.
1998: Caroline Roozendaal; A W Van Milligen de Wit; Elizabeth B Haagsma; Gerda Horst; C Schwarze; H H Peter; Jan H Kleibeuker; J W Cohen Tervaert; Pieter C Limburg; Cees G M Kallenberg
Antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis: defined specificities may be associated with distinct clinical features.
The American journal of medicine 1998;105(5):393-9.
1998: Marc Bijl; T van Lopik; Pieter C Limburg; P E Spronk; S M Jaegers; L A Aarden; R J T Smeenk; G G Kallenberg
Do elevated levels of serum-soluble fas contribute to the persistence of activated lymphocytes in systemic lupus erythematosus?
Journal of autoimmunity 1998;11(5):457-63.
1998: Casper F M Franssen; Coen A Stegeman; WW Oost-Kort; Cees G M Kallenberg; Pieter C Limburg; Anton T M G Tiebosch; Paul E de Jong; J W Cohen Tervaert
Determinants of renal outcome in anti-myeloperoxidase-associated necrotizing crescentic glomerulonephritis.
Journal of the American Society of Nephrology : JASN 1998;9(10):1915-23.
1998: Caroline Roozendaal; M H Zhao; Gerda Horst; CM Lockwood; Jan H Kleibeuker; Pieter C Limburg; GF Nelis; Cees G M Kallenberg
Catalase and alpha-enolase: two novel granulocyte autoantigens in inflammatory bowel disease (IBD).
Clinical and experimental immunology 1998;112(1):10-6.
1998: Pieter L Jager; Bouke P C Hazenberg; EJ Franssen; Pieter C Limburg; Martin H van Rijswijk; D Albertus Piers
Kinetic studies with iodine-123-labeled serum amyloid P component in patients with systemic AA and AL amyloidosis and assessment of clinical value.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1998;39(4):699-706.
1998: Caroline Roozendaal; Gerda Horst; K Pogány; A W van Milligen de Wit; Jan H Kleibeuker; Elizabeth B Haagsma; Pieter C Limburg; Cees G M Kallenberg
Prevalence and clinical significance of anti-lactoferrin autoantibodies in inflammatory bowel diseases and primary sclerosing cholangitis.
Advances in experimental medicine and biology 1998;443():313-9.
1997: Hendrika Bootsma; PE Spronk; E J Ter Borg; E J Hummel; G de Boer; Pieter C Limburg; Cees G M Kallenberg
The predictive value of fluctuations in IgM and IgG class anti-dsDNA antibodies for relapses in systemic lupus erythematosus. A prospective long-term observation.
Annals of the rheumatic diseases 1997;56(11):661-6.
1997: Miek A van Leeuwen; Martin H van Rijswijk; W J Sluiter; P L C M van Riel; IH Kuper; L B A Van De Putte; M B Pepys; Pieter C Limburg
Individual relationship between progression of radiological damage and the acute phase response in early rheumatoid arthritis. Towards development of a decision support system.
The Journal of rheumatology 1997;24(1):20-7.
1996: Peter Heeringa; Jacob Van Den Born; Elisabeth Brouwer; K M Dolman; Pieter A Klok; Minke G Huitema; Pieter C Limburg; Marinka A H Bakker; Jo H M Berden; M R Daha; Cees G M Kallenberg
Elastase, but not proteinase 3 (PR3), induces proteinuria associated with loss of glomerular basement membrane heparan sulphate after in vivo renal perfusion in rats.
Clinical and experimental immunology 1996;105(2):321-9.
1996: P E Spronk; Hendrika Bootsma; Gerda Horst; Minke G Huitema; Pieter C Limburg; J W Cohen Tervaert; Cees G M Kallenberg
Antineutrophil cytoplasmic antibodies in systemic lupus erythematosus.
British journal of rheumatology 1996;35(7):625-31.
1996: P E Spronk; Gerda Horst; B T Van Der Gun; Pieter C Limburg; Cees G M Kallenberg
Anti-dsDNA production coincides with concurrent B and T cell activation during development of active disease in systemic lupus erythematosus (SLE).
Clinical and experimental immunology 1996;104(3):446-53.
1996: G J Veldhuis; P H B Willemse; Nanno H Mulder; Pieter C Limburg; Elisabeth G E de Vries
Potential use of recombinant human interleukin-6 in clinical oncology.
Leukemia & lymphoma 1996;20(5-6):373-9.
1996: Hendrika Bootsma; P E Spronk; E J Hummel; G de Boer; E J ter Borg; Pieter C Limburg; Cees G M Kallenberg
Anti-double stranded DNA antibodies in systemic lupus erythematosus: detection and clinical relevance of IgM-class antibodies.
Scandinavian journal of rheumatology 1996;25(6):352-9.
1995: G J Veldhuis; P H B Willemse; Dirk T Sleijfer; Winette T A van der Graaf; Harry J M Groen; Pieter C Limburg; Nanno H Mulder; Elisabeth G E de Vries
Toxicity and efficacy of escalating dosages of recombinant human interleukin-6 after chemotherapy in patients with breast cancer or non-small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(10):2585-93.
1995: Miek A van Leeuwen; J Westra; Pieter C Limburg; P L C M van Riel; Martin H van Rijswijk
Clinical significance of interleukin-6 measurement in early rheumatoid arthritis: relation with laboratory and clinical variables and radiological progression in a three year prospective study.
Annals of the rheumatic diseases 1995;54(8):674-7.
1995: J Nieken; Nanno H Mulder; J Buter; Edo Vellenga; Pieter C Limburg; D A Piers; Elisabeth G E de Vries
Recombinant human interleukin-6 induces a rapid and reversible anemia in cancer patients.
Blood 1995;86(3):900-5.
1995: Hendrika Bootsma; P Spronk; R H W M Derksen; G de Boer; H Wolters-Dicke; J Hermans; Pieter C Limburg; F Gmelig-Meyling; L Kater; Cees G M Kallenberg
Prevention of relapses in systemic lupus erythematosus.
Lancet 1995;345(8965):1595-9.
1995: P E Spronk; Pieter C Limburg; Cees G M Kallenberg
Serological markers of disease activity in systemic lupus erythematosus.
Lupus 1995;4(2):86-94.
1995: Miek A van Leeuwen; J Westra; Pieter C Limburg; P L C M van Riel; Martin H van Rijswijk
Interleukin-6 in relation to other proinflammatory cytokines, chemotactic activity and neutrophil activation in rheumatoid synovial fluid.
Annals of the rheumatic diseases 1995;54(1):33-8.
1995: Miek A van Leeuwen; J Westra; P L C M van Riel; Pieter C Limburg; Martin H van Rijswijk
IgM, IgA, and IgG rheumatoid factors in early rheumatoid arthritis predictive of radiological progression?
Scandinavian journal of rheumatology 1995;24(3):146-53.
1994: Elisabeth Brouwer; Coen A Stegeman; Minke G Huitema; Pieter C Limburg; Cees G M Kallenberg
T cell reactivity to proteinase 3 and myeloperoxidase in patients with Wegener's granulomatosis (WG).
Clinical and experimental immunology 1994;98(3):448-53.
1994: J W Cohen Tervaert; Coen A Stegeman; Elisabeth Brouwer; A H Mulder; Pieter C Limburg; Cees G M Kallenberg
Anti-neutrophil cytoplasmic antibodies: a new class of autoantibodies in glomerulonephritis, vasculitis and other inflammatory disorders.
The Netherlands journal of medicine 1994;45(6):262-72.
1994: A H Mulder; Peter Heeringa; Elisabeth Brouwer; Pieter C Limburg; Cees G M Kallenberg
Activation of granulocytes by anti-neutrophil cytoplasmic antibodies (ANCA): a Fc gamma RII-dependent process.
Clinical and experimental immunology 1994;98(2):270-8.
1994: M M van Gameren; P H B Willemse; Nanno H Mulder; Pieter C Limburg; H J Groen; Edo Vellenga; Elisabeth G E de Vries
Effects of recombinant human interleukin-6 in cancer patients: a phase I-II study.
Blood 1994;84(5):1434-41.
1994: P E Spronk; Hendrika Bootsma; Minke G Huitema; Pieter C Limburg; Cees G M Kallenberg
Levels of soluble VCAM-1, soluble ICAM-1, and soluble E-selectin during disease exacerbations in patients with systemic lupus erythematosus (SLE); a long term prospective study.
Clinical and experimental immunology 1994;97(3):439-44.
1994: P E Spronk; E J ter Borg; Minke G Huitema; Pieter C Limburg; Cees G M Kallenberg
Changes in levels of soluble T-cell activation markers, sIL-2R, sCD4 and sCD8, in relation to disease exacerbations in patients with systemic lupus erythematosus: a prospective study.
Annals of the rheumatic diseases 1994;53(4):235-9.
1994: A H Mulder; J Broekroelofs; Gerda Horst; Pieter C Limburg; G F Nelis; Cees G M Kallenberg
Anti-neutrophil cytoplasmic antibodies (ANCA) in inflammatory bowel disease: characterization and clinical correlates.
Clinical and experimental immunology 1994;95(3):490-7.
1994: Miek A van Leeuwen; Désirée van der Heijde; Martin H van Rijswijk; Pieternella Houtman; P L C M van Riel; L B A Van De Putte; Pieter C Limburg
Interrelationship of outcome measures and process variables in early rheumatoid arthritis. A comparison of radiologic damage, physical disability, joint counts, and acute phase reactants.
The Journal of rheumatology 1994;21(3):425-9.
1993: J B M Kuks; Pieter C Limburg; Gerda Horst; H J Oosterhuis
Antibodies to skeletal muscle in myasthenia gravis. Part 3. Relation with clinical course and therapy.
Journal of the neurological sciences 1993;120(2):168-73.
1993: J B M Kuks; Pieter C Limburg; Gerda Horst; H J Oosterhuis
Antibodies to skeletal muscle in myasthenia gravis. Part 2. Prevalence in non-thymoma patients.
Journal of the neurological sciences 1993;120(1):78-81.
1993: J B M Kuks; Pieter C Limburg; Gerda Horst; Jan Dijksterhuis; H J Oosterhuis
Antibodies to skeletal muscle in myasthenia gravis. Part 1. Diagnostic value for the detection of thymoma.
Journal of the neurological sciences 1993;119(2):183-8.
1993: A H Mulder; Gerda Horst; Miek A van Leeuwen; Pieter C Limburg; Cees G M Kallenberg
Antineutrophil cytoplasmic antibodies in rheumatoid arthritis. Characterization and clinical correlations.
Arthritis and rheumatism 1993;36(8):1054-60.
1993: P E Spronk; B T vd Gun; Pieter C Limburg; Cees G M Kallenberg
B cell activation in clinically quiescent systemic lupus erythematosus (SLE) is related to immunoglobulin levels, but not to levels of anti-dsDNA, nor to concurrent T cell activation.
Clinical and experimental immunology 1993;93(1):39-44.
1993: Miek A van Leeuwen; Martin H van Rijswijk; Désirée van der Heijde; Gerard te Meerman; P L C M van Riel; Pieternella Houtman; L B A Van De Putte; Pieter C Limburg
The acute-phase response in relation to radiographic progression in early rheumatoid arthritis: a prospective study during the first three years of the disease.
British journal of rheumatology 1993;32 Suppl 3():9-13.
1993: A H Mulder; Gerda Horst; Elizabeth B Haagsma; Pieter C Limburg; Jan H Kleibeuker; Cees G M Kallenberg
Prevalence and characterization of neutrophil cytoplasmic antibodies in autoimmune liver diseases.
Hepatology (Baltimore, Md.) 1993;17(3):411-7.
1993: A H Mulder; J Broekroelofs; Gerda Horst; Pieter C Limburg; G F Nelis; Cees G M Kallenberg
Antineutrophil antibodies in inflammatory bowel disease recognize different antigens.
Advances in experimental medicine and biology 1993;336():519-22.
1993: H A Cats; J W Cohen Tervaert; R van Wijk; Pieter C Limburg; Cees G M Kallenberg
Anti-neutrophil cytoplasmic antibodies in giant cell arteritis and polymyalgia rheumatica.
Advances in experimental medicine and biology 1993;336():363-6.
1992: P E Spronk; E J ter Borg; Pieter C Limburg; Cees G M Kallenberg
Plasma concentration of IL-6 in systemic lupus erythematosus; an indicator of disease activity?
Clinical and experimental immunology 1992;90(1):106-10.
1992: Bonne Biesma; P H B Willemse; Nanno H Mulder; Dirk T Sleijfer; Jourik A Gietema; R Mull; Pieter C Limburg; J Bouma; Edo Vellenga; Elisabeth G E de Vries
Effects of interleukin-3 after chemotherapy for advanced ovarian cancer.
Blood 1992;80(5):1141-8.
1992: Pieter E Postmus; Jourik A Gietema; O Damsma; Bonne Biesma; Pieter C Limburg; Edo Vellenga; Elisabeth G E de Vries
Effects of recombinant human interleukin-3 in patients with relapsed small-cell lung cancer treated with chemotherapy: a dose-finding study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(7):1131-40.
1992: Jourik A Gietema; Pieter E Postmus; Bonne Biesma; Pieter C Limburg; Edo Vellenga; E G de Vries
Acute-phase response in patients given rhIL-3 after chemotherapy.
Lancet 1992;339(8809):1616-7.
1992: J B M Kuks; Pieter C Limburg; H J Oosterhuis; T Hauw The
Antibodies to acetylcholine receptors in myasthenia gravis. In vitro synthesis by peripheral blood lymphocytes before and after thymectomy.
Clinical and experimental immunology 1992;87(2):246-50.
1992: A S Dofferhoff; H J de Jong; V J Bom; Jan van der Meer; Pieter C Limburg; Hillie G de Vries-Hospers; J Marrink; P O Mulder; J Weits
Complement activation and the production of inflammatory mediators during the treatment of severe sepsis in humans.
Scandinavian journal of infectious diseases 1992;24(2):197-204.
1991: Cees G M Kallenberg; Hendrika Bootsma; Pieter C Limburg; R H Derksen
[Determination of antibodies against double-stranded DNA; when and which test?].
Nederlands tijdschrift voor geneeskunde 1991;135(46):2188-9.
1991: E G de Vries; P H Willemse; Bonne Biesma; A C Stern; Pieter C Limburg; Edo Vellenga
Flare-up of rheumatoid arthritis during GM-CSF treatment after chemotherapy.
Lancet 1991;338(8765):517-8.
1991: A S Dofferhoff; Edo Vellenga; Pieter C Limburg; A van Zanten; P O Mulder; J Weits
Tumour necrosis factor (cachectin) and other cytokines in septic shock: a review of the literature.
The Netherlands journal of medicine 1991;39(1-2):45-62.
1991: Jaap E Tulleken; Pieter C Limburg; Frits A J Muskiet; K M Kazemier; I K Boomgaardt; Martin H van Rijswijk
The effect of dietary energy percentage of fat and its P/S ratio on incorporation of n-3 PUFA and leukotriene production during fish oil supplementation in healthy volunteers.
European journal of clinical nutrition 1991;45(8):383-92.
1991: J W Cohen Tervaert; Pieter C Limburg; J D Elema; Minke G Huitema; Gerda Horst; T H The; Cees G M Kallenberg
Detection of autoantibodies against myeloid lysosomal enzymes: a useful adjunct to classification of patients with biopsy-proven necrotizing arteritis.
The American journal of medicine 1991;91(1):59-66.
1991: E J ter Borg; Gerda Horst; E Hummel; Pieter C Limburg; Cees G M Kallenberg
Rises in anti-double stranded DNA antibody levels prior to exacerbations of systemic lupus erythematosus are not merely due to polyclonal B cell activation.
Clinical immunology and immunopathology 1991;59(1):117-28.
1991: J B M Kuks; H J Oosterhuis; Pieter C Limburg; T Hauw The
Anti-acetylcholine receptor antibodies decrease after thymectomy in patients with myasthenia gravis. Clinical correlations.
Journal of autoimmunity 1991;4(2):197-211.
1991: Bonne Biesma; P H B Willemse; Edo Vellenga; Pieter C Limburg; Jan G Aalders; E G de Vries
[The hematopoietic growth factor GM-CSF in chemotherapy for ovarian carcinoma].
Nederlands tijdschrift voor geneeskunde 1991;135(10):420-4.
1991: Elisabeth Brouwer; J W Cohen Tervaert; Gerda Horst; Minke G Huitema; M van der Giessen; Pieter C Limburg; Cees G M Kallenberg
Predominance of IgG1 and IgG4 subclasses of anti-neutrophil cytoplasmic autoantibodies (ANCA) in patients with Wegener's granulomatosis and clinically related disorders.
Clinical and experimental immunology 1991;83(3):379-86.
1991: E J ter Borg; Gerda Horst; Pieter C Limburg; Walther J van Venrooij; Cees G M Kallenberg
Changes in levels of antibodies against the 70 kDa and a polypeptides of the U1RNP complex in relation to exacerbations of systemic lupus erythematosus.
The Journal of rheumatology 1991;18(3):363-7.
1991: S H Yap; Han Moshage; Bouke P C Hazenberg; H M Roelofs; J Bijzet; Pieter C Limburg; L A Aarden; Martin H van Rijswijk
Tumor necrosis factor (TNF) inhibits interleukin (IL)-1 and/or IL-6 stimulated synthesis of C-reactive protein (CRP) and serum amyloid A (SAA) in primary cultures of human hepatocytes.
Biochimica et biophysica acta 1991;1091(3):405-8.
1991: E J ter Borg; Gerda Horst; Pieter C Limburg; Cees G M Kallenberg
Shifts of anti-Sm-specific antibodies in patients with systemic lupus erythematosus: analysis by counter-immunoelectrophoresis, immunoblotting and RNA-immunoprecipitation.
Journal of autoimmunity 1991;4(1):155-64.
1990: E J ter Borg; Harry J M Groen; Gerda Horst; Pieter C Limburg; A A Wouda; Cees G M Kallenberg
Clinical associations of antiribonucleoprotein antibodies in patients with systemic lupus erythematosus.
Seminars in arthritis and rheumatism 1990;20(3):164-73.
1990: E J ter Borg; Gerda Horst; Pieter C Limburg; Martin H van Rijswijk; Cees G M Kallenberg
C-reactive protein levels during disease exacerbations and infections in systemic lupus erythematosus: a prospective longitudinal study.
The Journal of rheumatology 1990;17(12):1642-8.
1990: E J ter Borg; Gerda Horst; Pieter C Limburg; Cees G M Kallenberg
Changes in plasma levels of interleukin-2 receptor in relation to disease exacerbations and levels of anti-dsDNA and complement in systemic lupus erythematosus.
Clinical and experimental immunology 1990;82(1):21-6.
1990: Jaap E Tulleken; Pieter C Limburg; Frits A J Muskiet; Martin H van Rijswijk
Vitamin E status during dietary fish oil supplementation in rheumatoid arthritis.
Arthritis and rheumatism 1990;33(9):1416-9.
1990: J W Cohen Tervaert; roel goldschmeding; J D Elema; Pieter C Limburg; M van der Giessen; Minke G Huitema; M I Koolen; R J Hené; T H The; G K van der Hem
Association of autoantibodies to myeloperoxidase with different forms of vasculitis.
Arthritis and rheumatism 1990;33(8):1264-72.
1990: E J ter Borg; Gerda Horst; E J Hummel; Pieter C Limburg; Cees G M Kallenberg
Measurement of increases in anti-double-stranded DNA antibody levels as a predictor of disease exacerbation in systemic lupus erythematosus. A long-term, prospective study.
Arthritis and rheumatism 1990;33(5):634-43.
1990: H van der Tempel; Jaap E Tulleken; Pieter C Limburg; Frits A J Muskiet; Martin H van Rijswijk
Effects of fish oil supplementation in rheumatoid arthritis.
Annals of the rheumatic diseases 1990;49(2):76-80.
1990: Cees G M Kallenberg; E J ter Borg; Dick Jaarsma; Pieter C Limburg
Detection of autoantibodies to ribonucleoproteins by counter-immunoelectropheresis, immunoblotting and RNA-immunoprecipitation: comparison of results.
Clinical and experimental rheumatology 1990;8(1):35-40.
1988: E J ter Borg; Gerda Horst; E Hummel; Dick Jaarsma; Pieter C Limburg; Cees G M Kallenberg
Sequential development of antibodies to specific Sm polypeptides in a patient with systemic lupus erythematosus: evidence for independent regulation of anti-double-stranded DNA and anti-Sm antibody production.
Arthritis and rheumatism 1988;31(12):1563-7.
1988: Han Moshage; H M Roelofs; J F van Pelt; Bouke P C Hazenberg; Miek A van Leeuwen; Pieter C Limburg; L A Aarden; S H Yap
The effect of interleukin-1, interleukin-6 and its interrelationship on the synthesis of serum amyloid A and C-reactive protein in primary cultures of adult human hepatocytes.
Biochemical and biophysical research communications 1988;155(1):112-7.
1988: Cees G M Kallenberg; F van Dissel-Emiliani; Minke G Huitema; Pieter C Limburg; T H The
B-cell proliferation and differentiation in systemic lupus erythematosus and mixed connective tissue disease.
Journal of clinical & laboratory immunology 1988;26(2):55-61.
1988: Miek A van Leeuwen; J Westra; Pieter C Limburg; H J de Jong; J Marrink; Martin H van Rijswijk
Quantitation of IgM, IgA and IgG rheumatoid factors by ELISA in rheumatoid arthritis and other rheumatic disorders.
Scandinavian journal of rheumatology. Supplement 1988;75():25-31.
1986: Pieternella Houtman; C G Kallenberg; Pieter C Limburg; Miek A van Leeuwen; Martin H van Rijswijk; T H The
Fluctuations in anti-nRNP levels in patients with mixed connective tissue disease are related to disease activity as part of a polyclonal B cell response.
Annals of the rheumatic diseases 1986;45(10):800-8.
1985: Pieternella Houtman; C G Kallenberg; Pieter C Limburg; M G Huitema; Martin H van Rijswijk; T H The
Quantitation of antibodies to nucleoribonucleoprotein by ELISA: relation between antibody levels and disease activity in patients with connective tissue disease.
Clinical and experimental immunology 1985;62(3):696-704.